Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher toutes les espèces
Afficher tous les synonymes
Sélectionnez vos espèces et l'application
anti-Rat (Rattus) Anticorps:
Vous arrivez à notre recherche pré-filtrée.
Human Polyclonal GCP2 Primary Antibody pour WB - ABIN520075
Vaithilingam, Quayum, Joglekar, Jensen, Hardikar, Oberholzer, Guillemin, Tuch: Effect of alginate encapsulation on the cellular transcriptome of human islets. dans Biomaterials 2011
Parenchymal polymorphonuclear myeloid-derived suppressor cell (PMN (Montrer TBCE Anticorps)-MDSC), have a positive correlation with IL1a (Montrer IL1A Anticorps), IL8 (Montrer IL8 Anticorps), CXCL5 (Montrer CXCL5 Anticorps), and Mip-1a (Montrer CCL3 Anticorps), suggesting they may attract PMN (Montrer TBCE Anticorps)-MDSC into the tumor
These data identify suppression of CXCL2 (Montrer CXCL2 Anticorps) and CXCL5 (Montrer CXCL5 Anticorps) chemoattractant expression by 11beta-HSD1 (Montrer HSD11B1 Anticorps) as a novel mechanism with potential for regulation of neutrophil recruitment to the injured myocardium, and cardiac fibroblasts as a key site for intracellular glucocorticoid regeneration during acute inflammation following myocardial injury.
IL-17RA (Montrer IL17RA Anticorps) regulates CXL-1 and 5 production in the lungs during the adaptive response.
STAT3 (Montrer STAT3 Anticorps) is required for maximal OSM (Montrer OSM Anticorps)-induced CXCL5 (Montrer CXCL5 Anticorps) expression.
CXCL5 (Montrer CXCL5 Anticorps) has a role in neutrophil recruitment in TH17-mediated glomerulonephritis
Since adaptive villus growth occurs despite impaired CXCL5 (Montrer CXCL5 Anticorps) expression and enhanced angiogenesis, this suggests that the growth of new blood vessels is not needed for resection-induced mucosal surface area expansion following massive SBR (Montrer NXF1 Anticorps).
CXCL5 (Montrer CXCL5 Anticorps) regulates pulmonary responses to infection and plays a central role in conferring clock control of inflammation.
findings demonstrated that CXCL1 (Montrer CXCL1 Anticorps) and CXCL5 (Montrer CXCL5 Anticorps) are increased in circulation with onset of T2D, are produced by islets under stress, and synergistically affect islet function, suggesting that these chemokines participate in pathogenesis of T2D.
TLR2-induced epithelial-derived CXCL5 (Montrer CXCL5 Anticorps) is critical for polymorphonuclear leukocyte-driven destructive inflammation in pulmonary tuberculosis.
Our data suggest that the differential regulation of the chemokine CXCL5 between osteoblasts and endothelial cells upon FGF2 treatment is involved in Hematopoietic stem cell mobilization from the osteoblast niche or bone marrow to peripheral blood.
There was underexpression of the majority of genes after sunitinib treatment. The lower expression levels of IGFBP1 (Montrer IGFBPI Anticorps), CCL20 (Montrer CCL20 Anticorps), CXCL6 and FGB (Montrer FGB Anticorps) were confirmed by qRT-PCR in all cases. The downregulation of gene expression leads us to search for methylation as a mechanism of action of the tyrosine kinase (Montrer TXK Anticorps) inhibitors
CXCL6 level is high in the serum of chronic hepatitis B patients.CXCL6 promotes human hepatocyte proliferation through the CXCR1-NFkappaB pathway and inhibits collagen I secretion by hepatic stellate cells.
The role of PITX2 (Montrer PITX2 Anticorps) in glaucoma may be mediated partly by regulating the expression of CXCL6 and BBS5 (Montrer BBS5 Anticorps) and thus affecting immune functions and intraocular pressure.
This is the first study to note that elevated systemic CCL5 (Montrer CCL5 Anticorps) and CXCL6 were associated with moderate/severe lumbar disc degeneration. These chemokines may be systemic biomarkers for the diagnosis and monitoring of disc degeneration.
The neutrophil-recruiting chemokine (Montrer CCL1 Anticorps) GCP-2/CXCL6 is expressed in cystic fibrosis (Montrer S100A8 Anticorps) airways and retains its functional properties after binding to extracellular DNA.
HIF-1alpha (Montrer HIF1A Anticorps) promotes HCC (Montrer FAM126A Anticorps) progression and metastasis by upregulating CXCL6 transcription in HCC (Montrer FAM126A Anticorps) cells.
Expression of the CXCL8 (Montrer IL8 Anticorps), CXCL6 and CXCL1 (Montrer CXCL1 Anticorps) genes are under the primary control of 1,25-dihydroxyvitamin D3 and its receptor.
Data suggest that expression of CXCL6 in trophoblasts is up-regulated during pregnancy development/placentation; CXCL6 expression inhibits trophoblast cell migration and invasion by down-regulating activity of MMP2 (matrix metalloproteinase 2 (Montrer MMP2 Anticorps)).
Overexpression of GCP-2 (Montrer FOLH1 Anticorps) in mesenchymal stem cells has the potential to enhance their angiogenic and survival properties.
Studies show that functional blocking of GCP-2 (Montrer FOLH1 Anticorps) inhibits tumor growth and metastases.
mouse homolog is a member of the CXC chemokine family, is a neutrophil chemoattractant and is rapidly induced in response to muscle injury
C-X-C motif chemokine 5
, CXC chemokine LIX
, chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2)
, cytokine LIX
, small-inducible cytokine B5
, granulocyte chemotactic protein-2
, small inducible cytokine B subfamily, member 5
, small inducible cytokine subfamily B, member 15
, C-X-C motif chemokine 6
, Small inducible cytokine subfamily B (Cys-X-Cys), member b
, chemokine alpha 3
, granulocyte chemotactic protein 2
, small inducible cytokine subfamily B (Cys-X-Cys), member 6 (granulocyte chemotactic protein 2)
, small-inducible cytokine B6
, chemokine (C-X-C motif) ligand 5
, inducible cytokine subfamily B (Cys-X-Cys), member 6